+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Therapeutic Area Market Research Reports

Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Immuno-Oncology - Thematic Research - Product Thumbnail Image

Immuno-Oncology - Thematic Research

  • Report
  • May 2022
  • 167 Pages
  • Global
From
Vaginal Cancer - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Vaginal Cancer - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 103 Pages
  • Global
From
Prescriber Opinions on Biosimilars in Immunology - Product Thumbnail Image

Prescriber Opinions on Biosimilars in Immunology

  • Report
  • March 2021
  • 45 Pages
  • Global
From
Heart Failure: Epidemiology Forecast to 2028 - Product Thumbnail Image

Heart Failure: Epidemiology Forecast to 2028

  • Report
  • December 2019
  • 63 Pages
  • Global
From
From
From
Loading Indicator

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs. Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more